Globus Medical, Inc. (NYSE: GMED) has announced a major leadership transition alongside preliminary second-quarter results that show continued momentum in its core spine and enabling technologies ...

Keith brings a sharp strategic mindset and a results-orientated leadership style with a clear understanding of how to drive performance across an organization,” said David C. Paul, Globus Medical ...

Globus Medical, Inc. GMED recently introduced DuraPro, a next-generation oscillating system with Excelsius navigation capabilities. DuraPro is the latest addition to the company’s Power Portfolio, ...

On April 3, 2025, Nevro Corp. filed a notice of data breach with the Attorney General of Texas after discovering that information in the company’s ...

Nevro NVRO is well-poised for growth in the coming quarters, courtesy of its business expansion plans and restructuring activities. The optimism, led by a decent preliminary full-year 2024 results ...

The maker of an electrical implant that treats leg and back pain posted revenue of $105.5 million in the period, which also topped Street forecasts.

The maker of an electrical implant that treats leg and back pain posted revenue of $105.5 million in the period, which also topped Street forecasts. Four analysts surveyed by Zacks expected $104 ...

The maker of an electrical implant that treats leg and back pain posted revenue of $105.5 million in the period, which also topped Street forecasts. Four analysts surveyed by Zacks expected $104 ...

Nevro's full-year 2024 worldwide revenue was $408.5 million, a decrease of 3.9% as reported and 4.0% on a constant currency basis, compared with $425.2 million for full-year 2023.

Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results PR Newswire REDWOOD CITY, Calif., March 4, 2025 REDWOOD CITY ...